There could be some delays because patients will need to undergo a verification process known as prior authorization to determine whether they qualify for the low-cost drugs
That was my very first day
Philip Pape: 9:55 So I want a little bit of a kick in the pants for my brain related genes, my appetite, and I guess I guess the challenge here is, right now we don't have clinical data on the microdosing you know to, to know how effective it is really, although we could extrapolate and we could use basic math and like okay, well, if I take half the dose, I might have to have the result, but we can't oversimplify, right
Figure 2: Changes in A) daily food intake, B) weekly food intake, C) daily body weight, and D) overall change in body weight
Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability